Original Research

Published on 19 Sep 2024

Long-term effects of siponimod on cardiovascular and autonomic nervous system in secondary progressive multiple sclerosis

in Neuropharmacology

Victor Constantinescu
Rocco Haase
Katja Akgün
Tjalf Ziemssen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1431380

765 views

Original Research

Published on 18 Sep 2024

Lentivirus-mediated RNA interference targeting HMGB1 modulates AQP1 to reduce pain induced by chronic compression of the dorsal root ganglia

in Neuropharmacology

Jinlu Li
Kaihong Yang
Fuchao Yao
Hui Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1469223

843 views

Review

Published on 17 Sep 2024

Gut microbiota metabolites: potential therapeutic targets for Alzheimer’s disease?

in Neuropharmacology

Shanshan Zhang
Jing Lu
Ziqi Jin
Hanying Xu
Dongmei Zhang
Jianan Chen
Jian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1459655

2,326 views
1 citation

Original Research

Published on 16 Sep 2024

Novel multitarget analgesic candidate SZV-1287 demonstrates potential disease-modifying effects in the monoiodoacetate-induced osteoarthritis mouse model

in Neuropharmacology

Ádám István Horváth
Kata Bölcskei
Nikolett Szentes
Éva Borbély
Valéria Tékus
Bálint Botz
Kitti Rusznák
Anett Futácsi
Boldizsár Czéh
Péter Mátyus

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377081

1,305 views

Original Research

Published on 13 Sep 2024

Oleuropein enhances proteasomal activity and reduces mutant huntingtin-induced cytotoxicity

in Neuropharmacology

Zih-Ning Huang
Sin-Yi Lee
Jie-Mao Chen
Zih-Ting Huang
Lu-Shiun Her

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1459909

722 views

Review

Published on 13 Sep 2024

The leukotriene receptor antagonist montelukast as a potential therapeutic adjuvant in multiple sclerosis – a review

in Neuropharmacology

Frank Pietrantonio
Alex Serreqi
Horst Zerbe
Per Svenningsson
Ludwig Aigner

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1450493

1,343 views

Mini Review

Published on 12 Sep 2024

Flavonoids as therapeutic agents for epilepsy: unveiling anti-inflammatory and antioxidant pathways for novel treatments

in Neuropharmacology

Ya Zhang
Xizhuo Hu
Li-Qun Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1457284

1,277 views

Editorial

Published on 11 Sep 2024

Editorial: Pharmacological actions of drugs in the brain: exploring the intricacies and potential therapeutic applications

in Neuropharmacology

Christina Dalla
Nouria Lakhdar-Ghazal
Tanya Calvey
Giuseppe Di Giovanni

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1486719

429 views

Review

Published on 11 Sep 2024

Cannabidiol, a plant-derived compound, is an emerging strategy for treating cognitive impairments: comprehensive review of randomized trials

in Neuropharmacology

Adriana Yndart Arias
Kamila Vadell
Arti Vashist
Nagesh Kolishetti
Madepalli K. Lakshmana
Madhavan Nair
Juan P. Liuzzi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403147

1,811 views

Original Research

Published on 11 Sep 2024

Isoliquiritigenin ameliorates abnormal oligodendrocyte development and behavior disorders induced by white matter injury

in Neuropharmacology

Dong Wu
Wenjuan Zhou
Jingyi Du
Tiantian Zhao
Naigang Li
Fan Peng
Anna Li
Xinyue Zhang
Meihua Zhang
Aijun Hao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1473019

992 views

Systematic Review

Published on 06 Sep 2024

Effect of N-acetylcysteine on craving in substance use disorders (SUD): a meta-analysis of randomized controlled trials

in Neuropharmacology

Micol Cuocina
Giuseppe Aiello
Pierfelice Cutrufelli
Martina Rampello
Laura Rapisarda
Alessandro Rodolico
Giuseppina Cantarella
Maria Salvina Signorelli
Renato Bernardini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1462612

1,938 views

Original Research

Published on 06 Sep 2024

The role of 5-HTergic neuron activation in the rapid antidepressant-like effects of hypidone hydrochloride (YL-0919) in mice

in Neuropharmacology

Guang-Xiang Li
Jiao-Zhao Yan
Sun-Rui Sun
Xiao-Juan Hou
Yong-Yu Yin
Yun-Feng Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1428485

800 views

Original Research

Published on 04 Sep 2024

Polydatin ameliorates early brain injury after subarachnoid hemorrhage through up-regulating SIRT1 to suppress endoplasmic reticulum stress

in Neuropharmacology

Yuwei Han
Guangzhi Hao
Song Han
Tingzhun Zhu
Yushu Dong
Ligang Chen
Xinyu Yang
Xiaoming Li
Hai Jin
Guobiao Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1450238

1,223 views

Case Report

Published on 04 Sep 2024

Case report: Therapeutic drug monitoring and CYP2D6 phenoconversion in a protracted paroxetine intoxication

in Neuropharmacology

Alena Damborská
Lenka Hanáková
Eva Pindurová
Kateřina Horská

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1444857

1,039 views
1 citation

Original Research

Published on 04 Sep 2024

Liquiritin ameliorates painful diabetic neuropathy in SD rats by inhibiting NLRP3-MMP-9-mediated reversal of aquaporin-4 polarity in the glymphatic system

in Neuropharmacology

Shuai-Ying Jia
Wen-Qin Yin
Wen-Mei Xu
Jiang Li
Wei Yan
Jing-Yan Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1436146

1,120 views

Original Research

Published on 03 Sep 2024

Activation of EphrinB2/EphB2 signaling in the spine cord alters glia-neuron interactions in mice with visceral hyperalgesia following maternal separation

in Neuropharmacology

Shufen Guo
Yu Wang
Qingling Duan
Wei Gu
Qun Fu
Zhengliang Ma
Jiaping Ruan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1463339

767 views

Navigation group

Articles

Long-term effects of siponimod on cardiovascular and autonomic nervous system in secondary progressive multiple sclerosis

Lentivirus-mediated RNA interference targeting HMGB1 modulates AQP1 to reduce pain induced by chronic compression of the dorsal root ganglia

Gut microbiota metabolites: potential therapeutic targets for Alzheimer’s disease?

Novel multitarget analgesic candidate SZV-1287 demonstrates potential disease-modifying effects in the monoiodoacetate-induced osteoarthritis mouse model

Oleuropein enhances proteasomal activity and reduces mutant huntingtin-induced cytotoxicity

The leukotriene receptor antagonist montelukast as a potential therapeutic adjuvant in multiple sclerosis – a review

Flavonoids as therapeutic agents for epilepsy: unveiling anti-inflammatory and antioxidant pathways for novel treatments

Editorial: Pharmacological actions of drugs in the brain: exploring the intricacies and potential therapeutic applications

Cannabidiol, a plant-derived compound, is an emerging strategy for treating cognitive impairments: comprehensive review of randomized trials

Isoliquiritigenin ameliorates abnormal oligodendrocyte development and behavior disorders induced by white matter injury

Effect of N-acetylcysteine on craving in substance use disorders (SUD): a meta-analysis of randomized controlled trials

The role of 5-HTergic neuron activation in the rapid antidepressant-like effects of hypidone hydrochloride (YL-0919) in mice

Polydatin ameliorates early brain injury after subarachnoid hemorrhage through up-regulating SIRT1 to suppress endoplasmic reticulum stress

Case report: Therapeutic drug monitoring and CYP2D6 phenoconversion in a protracted paroxetine intoxication

Liquiritin ameliorates painful diabetic neuropathy in SD rats by inhibiting NLRP3-MMP-9-mediated reversal of aquaporin-4 polarity in the glymphatic system

Activation of EphrinB2/EphB2 signaling in the spine cord alters glia-neuron interactions in mice with visceral hyperalgesia following maternal separation